Brain Calcification

Gene: SLC20A2

Green List (high evidence)

SLC20A2 (solute carrier family 20 member 2)
EnsemblGeneIds (GRCh38): ENSG00000168575
EnsemblGeneIds (GRCh37): ENSG00000168575
OMIM: 158378, ClinGen, DECIPHER
SLC20A2 is in 8 panels

3 reviews

Yetong Chen (University of Melbourne)

Green List (high evidence)

Additional cases are reported.
PMID 35850697 reports 6 patients from the same family with primary familial brain calcification. A reported SLC20A2 variant (c.1723G > T, p.(Glu575*)) was identified in the family. Co-segregation of brain calcification and the SLC20A2 variant was observed.
PMID 34025715 reports 7 patients with brain calcifications. 5 of them were from the same family harbouring the SLC20A2 variable (c.806delC), revealing brain calcifications in multiple regions. Co-segregation of SLC20A2 and brain calcification was observed in this family. The rest are 2 unrelated patients with different SLC20A2 variants (c.1154delG and c.1154delG) who developed bilateral symmetric calcification.
Created: 27 Apr 2023, 5:52 p.m. | Last Modified: 27 Apr 2023, 5:52 p.m.
Panel Version: 1.51

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Basal ganglia calcification, idiopathic, 1, MIM# 213600

Publications

Teresa Zhao (Victorian Clinical Genetics Services)

Green List (high evidence)

PMID: 34267336 reported a 55 yo female born from healthy consanguineous parents.
- At 20 yo, she was diagnosed with basal ganglia clacification. No endocrine or metabolic disorders related to brain calcifications were found.
- At 28, she developed a psychotic disorder including delirium consistent with paranoia or delusional disorder that improved with aripiprazole.
- At 40s, she started with motor clumsiness, balance disturbance, and severe dysarthria. In recent years, asymmetric Parkinsonism was observed.
- Homozygous missense p.Arg71Cys was identified in the proband.
Created: 1 Nov 2021, 3:42 p.m. | Last Modified: 1 Nov 2021, 3:42 p.m.
Panel Version: 1.12

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Basal ganglia calcification MIM#213600

Publications

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

Bi-allelic association:

PMID 41458256: Reports a single individual a homozygous nonsense SLC20A2 variant presenting with infantile primary familial brain calcification, cerebral arterial vasculopathy and ischaemic stroke. Individual exhibited seizures, hypotonia, poor feeding, and extensive ischaemic changes.

PMID 35881308: reports two siblings from a consanguineous Turkish family with a homozygous splice‑site loss‑of‑function variant NM_006749.5:c.1794+1G>A. The affected children presented with severe paediatric‑onset features resembling congenital CMV infection: growth retardation, bilateral cataracts, microcephaly, seizures, cerebral atrophy, corpus callosum hypoplasia and brain microcalcifications.

PMID 34267336 reports a consanguineous family including a 55‑year‑old woman homozygous for the missense variant c.211C>T (p.Arg71Cys) who had extensive basal ganglia calcifications, psychiatric manifestations and progressive Parkinsonism.
Created: 26 Apr 2026, 5:45 p.m. | Last Modified: 26 Apr 2026, 5:46 p.m.
Panel Version: 2.6
Mono-allelic association: Over 50 families reported. Affected individuals can either be asymptomatic or show a wide spectrum of neuropsychiatric symptoms, including parkinsonism, dystonia, tremor, ataxia, dementia, psychosis, seizures, and chronic headache.
Created: 10 Sep 2020, 2:24 p.m. | Last Modified: 26 Apr 2026, 5:46 p.m.
Panel Version: 2.6

Mode of inheritance
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal

Phenotypes
Basal ganglia calcification, idiopathic, 1, MIM# 213600

Publications

Details

Mode of Inheritance
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
Phenotypes
  • Basal ganglia calcification, idiopathic, 1, MIM# 213600
OMIM
158378
ClinGen
SLC20A2
DECIPHER
SLC20A2
Clinvar variants
Variants in SLC20A2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

26 Apr 2026, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: SLC20A2 were set to 22327515; 23334463

26 Apr 2026, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: SLC20A2 was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal

10 Sep 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: slc20a2 has been classified as Green List (High Evidence).

10 Sep 2020, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: SLC20A2 were changed from to Basal ganglia calcification, idiopathic, 1, MIM# 213600

10 Sep 2020, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: SLC20A2 were set to

10 Sep 2020, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: SLC20A2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: SLC20A2 was added gene: SLC20A2 was added to Brain calcification_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: SLC20A2 was set to Unknown